Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

被引:22
|
作者
Li, Di [1 ,2 ,5 ,6 ]
Deng, Chaoqiang [1 ,2 ,5 ,6 ]
Wang, Shengping [4 ,5 ,6 ]
Li, Yuan [3 ,5 ,6 ]
Zhang, Yang [1 ,2 ,5 ,6 ]
Chen, Haiquan [1 ,2 ,5 ,6 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, State Key Lab Genet Engn, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dong An Rd, Shanghai 200032, Peoples R China
[4] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, Inst Thorac Oncol, Shanghai, Peoples R China
[6] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
adenocarcinoma in situ; minimally invasive adenocarcinoma; prognosis; secondary primary lung cancer; sublobar resection; SECTION COMPUTED-TOMOGRAPHY; LIMITED-RESECTION; IASLC/ATS/ERS CLASSIFICATION; RANDOMIZED-TRIAL; LOBECTOMY; DIAGNOSIS; OUTCOMES; IMPACT; TUMORS;
D O I
10.1016/j.jtcvs.2022.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods: Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results: After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10- year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1%(41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions: Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
引用
收藏
页码:1614 / +
页数:10
相关论文
共 50 条
  • [21] Follow-up of patients with completely resected lung cancer
    Downey, RJ
    CHEST, 1999, 115 (06) : 1487 - 1489
  • [22] ADENOCARCINOMA OF LUNG - HISTOLOGICAL FACTORS AFFECTING PROGNOSIS - A STUDY OF 38 PATIENTS WITH RESECTION AND 5-YEAR FOLLOW-UP
    HUKILL, PB
    STERN, H
    CANCER, 1962, 15 (03) : 504 - &
  • [23] Ten-year follow-up in patients with combined heart and kidney transplantation
    Trachiotis, GD
    Vega, JD
    Johnston, TS
    Berg, A
    Whelchel, J
    Smith, AL
    Lutz, J
    Kanter, KR
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (06): : 2065 - 2071
  • [24] Ten-year follow-up of mortality in patients undergoing PCI and CABG
    Kasai, T
    Miyauchi, K
    Okazaki, S
    Kawamura, M
    Daida, H
    CIRCULATION, 2003, 107 (19) : E159 - E159
  • [25] Ten-Year Follow-up of Patients with Epidemic Post Infectious Glomerulonephritis
    Pinto, Sergio Wyton L.
    Mastroianni-Kirsztajn, Gianna
    Sesso, Ricardo
    PLOS ONE, 2015, 10 (05):
  • [26] Lung Adenocarcinoma during Pregnancy: 11-Year Follow-Up
    Acosta Rojas, Angel
    Collazo-Lorduy, Ana
    Remon, Jordi
    Hernando Requejo, Ovidio
    Jimenez-Munarriz, Beatriz
    Rubio Rodriguez, Maria Carmen
    De Castro, Javier
    CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 892 - 895
  • [27] Ten-year follow-up of laser in situ keratomileusis for myopia of up to-10 diopters
    Alio, Jorge L.
    Muftuoglu, Orkun
    Ortiz, Dolores
    Perez-Santonja, Juan Jose
    Artola, Alberto
    Ayala, Maria Jose
    Garcia, Maria Jose
    De Luna, Gracia Castro
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (01) : 46 - 54
  • [28] Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma
    Su, Hang
    Gu, Chang
    She, Yunlang
    Xu, Long
    Yang, Ping
    Xie, Huikang
    Zhao, Shengnan
    Wu, Chunyan
    Xie, Dong
    Chen, Chang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 32 - +
  • [29] How to Follow up Patients After Curative Resection of Lung Cancer
    Hanna, Wael C.
    Keshavjee, Shaf
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2013, 25 (03) : 213 - 217
  • [30] MANAGEMENT AND FOLLOW-UP OF PATIENTS WITH ADENOCARCINOMA IN-SITU OF THE UTERINE CERVIX
    POYNOR, EA
    BARAKAT, RR
    HOSKINS, WJ
    GYNECOLOGIC ONCOLOGY, 1995, 57 (02) : 158 - 164